MedPath

A Study of The Effect of Magnesium Sulfate on End-Tidal CO2 and Pai

Phase 2
Recruiting
Conditions
End-Tidal CO2.
Registration Number
IRCT20210302050549N1
Lead Sponsor
Rafsanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
62
Inclusion Criteria

ASA I-II patients
20 to 60 years of age

Exclusion Criteria

Drug allergy to magnesium sulfate
Drug abuse
Any neuromuscular disease
(Ejection Fraction)EF < 40%
Hypotension or Bradycardia by more than 20% during anesthesia
Cardiac disease
Hepatic or Renal failure
Chronic respiratory failure
Morbid obesity

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
End-Tidal CO2. Timepoint: During surgery. Method of measurement: With capnograph device.;Pain severity. Timepoint: After surgery during recovery, second, sixth, 12th and 24th hours. Method of measurement: Using the VAS (Visual Analogue Scale).
Secondary Outcome Measures
NameTimeMethod
Blood Pressure. Timepoint: During Surgery. Method of measurement: Blood Pressure Cuff.;Heart Rate. Timepoint: During Surgery. Method of measurement: ECG (electrocardiogram) Monitoring.
© Copyright 2025. All Rights Reserved by MedPath